Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma

Samira Mostafazadeh; Shahla Gharenaghadehi; Fariba Abdal

doi:doi:10.11648/j.ijcocr.20251004.14

Research Article |

| Peer-Reviewed

Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma

Samira Mostafazadeh

, Shahla Gharenaghadehi, Fariba Abdal^*

Published in International Journal of Clinical Oncology and Cancer Research (Volume 10, Issue 4)

Received: 30 October 2025 Accepted: 10 November 2025 Published: 9 December 2025

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Objective: E-cadherin is a membranous glycoprotein that acts as an adhesive agent in intercellular communication, this marker level decreases in dysplastic condition, the aim of the present study is to evaluate the expression level of the mentioned marker on Oral Lichen Planus (OLP), Oral Leukoplakia (OL) and Oral Squamous Cell Carcinoma (OSCC) lesions. Methods: In this in-vitro study was conducted on 60 pararhyme blocks of patients with OL, OLP, and OSCC (n = 20) using Immunohistochemically (IHC) staining diagnosis were classified as follows: Code 0: Not painted Code 1: Less than 25% staining, Code 2: 25% - 50% staining, Code 3: 50% - 75% staining, Code 4: More than 75% staining and reported as proportional score and data were compared according to gender and lesion type using SPSS 22.0 Software and significance level of p < 0.05). Results: 60 blocks of 60 patients (30 males and 30 females) were included in the study. E-cadherin marker expression on IHC code I (< 25% staining) and code II (25% < 50%) was the most in OSCC (25%) and OL (30%) respectively and the least in OLP (10 and 20% respectively). In IHC code 3 (50% < 75%) and code IV (< 75%) was the most in OLP (40% and 30% respectively) and the least in OSCC (20% and 30% respectively).. There was no significant difference in marker expression according to gender and lesion type (p > 0.05). Conclusion: The results of this study show that changes in cadherin expression in leukoplakia and lichen planus compared to squamous cell carcinoma can be considered as an important factor in the expression of dysplasia changes.

Published in	International Journal of Clinical Oncology and Cancer Research (Volume 10, Issue 4)
DOI	10.11648/j.ijcocr.20251004.14
Page(s)	151-156
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Oral Leukoplakia, Oral Lichen Planus, Oral Squamous Cell Carcinoma, E-cadherin, Preneoplastic Lesions

References

[1]	Das RK, Pal M, Barui A, Paul RR, Chakraborty C, Ray AK, et al. Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression. J Clin Pathol. 2010; 63(10): 894-899. https://doi.org/10.1136/jcp.2010.078964
[2]	Sadri D, khodayari A, gharvan S. Prevalence of oral squamous cell carcinoma in a group of young and old iranian patients. Shiraz Univ Dent J. 2011; 12(2): 120-126.
[3]	Greenberg MS, Glick M. Burket's oral medicine: Diagnosis and Treatment. 12^th ed. Hamilton, ON: Bc Decker; 2015. 100-110.
[4]	Mostafazadeh S, Emamverdizadeh P, Abdal K, Forghani S. A comparative study of the frequency of myofibroblasts and macrophages between the oral and cutaneous squamous cell carcinoma. J Dent Res Dent Clin Dent Prospects. 2019; 13(4): 253-257. https://doi.org/10.15171/joddd.2019.039
[5]	Khiavi MM, Abdal K, Abbasi MM, Hamishehkar H, Aghbali AA, Salehi R, Sina M, Abdollahi B, Fotohi S. Comparison of injectable doxorubicin & its nanodrug complex chemotherapy for the treatment of 4-nitroquinoline-1-oxide induced oral squamous cell carcinoma in rats. Indian J Med Res 2017; 145: 112-7. https://doi.org/10.4103/ijmr.IJMR_542_14
[6]	Sina M, Abdal K, Ghertasi S, Mohmadi M, Aghbali A. investigate the association of mast cell concentration and microvascular density in tumoral tissues in oral squamous cell carcinoma. J Res Dent Sci. 2016; 12(4): 202-207. http://jrds.ir/article-1-642-en.html
[7]	S. V. Sowmya, Roopa S. Rao, Kavitha Prasad. Prediction of metastasis in oral squamous cell carcinoma through phenotypic evaluation and gene expression of E-cadherin, β-catenin, matrix metalloproteinase-2, and matrix metalloproteinase-9 biomarkers with clinical correlation. J Carcinog. 2020; 6(2): 8-20. https://doi.org/10.4103/jcar.JCar_8_20
[8]	Partheeban Balasundaram, Manoj Kumar Singh, et al. Study of β-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases. Diagn Pathol. 2014; 9: 145. https://doi.org/10.1186/1746-1596-9-145
[9]	Ryoichi Fujii, Yorihisa Imanishi, Katsushi Shibata, et al. Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 2014; 33(1): 40. https://doi.org/10.1186/1756-9966-33-40
[10]	Hesham Mohamed, Caj Haglund, Lauri Jouhi, et al. Expression and Role of E-Cadherin, β-Catenin, and Vimentin in Human Papillomavirus–Positive and Human Papillomavirus–Negative Oropharyngeal Squamous Cell Carcinoma. J Histochem Cytochem. 2020; 68(9): 595–606. https://doi.org/10.1369/00221554209508
[11]	Vijay Kumar, Abikshyeet Panda, Kailash Chandra Dash, et al. Immunohistochemical Expression of the Epithelial to Mesenchymal Transition Proteins E-cadherin and ß-catenin in Grades of Oral Squamous Cell Carcinoma. J Pharm Bioallied Sci. 2021; 13(1): 555–560. https://doi.org/10.4103/jpbs.JPBS_562_20
[12]	Jingping Zhou, Detao Tao, Qing Xu, et al. Expression of E-cadherin and vimentin in oral squamous cell carcinoma. Int J Clin Exp Pathol. 2015; 8(3): 3150–3154.
[13]	Sandhya Singh Kushwaha, Sonia Joshi, Karandeep Singh Arora, et al. Correlation of E-cadherin Immunohistochemical Expression with Histopathological Grading of Oral Squamous Cell Carcinoma. Contemp Clin Dent. 2019; 10(2): 232–238. https://doi.org/10.4103/ccd.ccd_624_18
[14]	Canto AM, Müller H, Freitas RR, Santos PS. Oral lichen planus (OLP): clinical and complementary diagnosis. An Bras Dermatol. 2010; 85(5): 669-75. https://doi.org/10.1590/s0365-05962010000500010
[15]	Silva BS, Castro CA, Von Zeidler SL, Sousa SC, Batista AC, Yamamoto-Silva FP. Altered β-catenin expression in oral mucosal dysplasia: a comparative study. J Appl Oral Sci. 2015; 23(5): 472-8. https://doi.org/10.1590/1678-775720150150
[16]	Bor-Hwang Kang, Chih-Wen Shu, Jian-Kang Chao, et al. HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma. Sci Rep. 2019; 9: 8932. https://doi.org//10.1038/s41598-019-45489-1

Cite This Article

Plain Text BibTeX RIS

APA Style

Mostafazadeh, S., Gharenaghadehi, S., Abdal, F. (2025). Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma. International Journal of Clinical Oncology and Cancer Research, 10(4), 151-156. https://doi.org/10.11648/j.ijcocr.20251004.14

Copy | Download

ACS Style

Mostafazadeh, S.; Gharenaghadehi, S.; Abdal, F. Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma. Int. J. Clin. Oncol. Cancer Res. 2025, 10(4), 151-156. doi: 10.11648/j.ijcocr.20251004.14

Copy | Download

AMA Style

Mostafazadeh S, Gharenaghadehi S, Abdal F. Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma. Int J Clin Oncol Cancer Res. 2025;10(4):151-156. doi: 10.11648/j.ijcocr.20251004.14

Copy | Download

@article{10.11648/j.ijcocr.20251004.14,
  author = {Samira Mostafazadeh and Shahla Gharenaghadehi and Fariba Abdal},
  title = {Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma},
  journal = {International Journal of Clinical Oncology and Cancer Research},
  volume = {10},
  number = {4},
  pages = {151-156},
  doi = {10.11648/j.ijcocr.20251004.14},
  url = {https://doi.org/10.11648/j.ijcocr.20251004.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20251004.14},
  abstract = {Objective: E-cadherin is a membranous glycoprotein that acts as an adhesive agent in intercellular communication, this marker level decreases in dysplastic condition, the aim of the present study is to evaluate the expression level of the mentioned marker on Oral Lichen Planus (OLP), Oral Leukoplakia (OL) and Oral Squamous Cell Carcinoma (OSCC) lesions. Methods: In this in-vitro study was conducted on 60 pararhyme blocks of patients with OL, OLP, and OSCC (n = 20) using Immunohistochemically (IHC) staining diagnosis were classified as follows: Code 0: Not painted Code 1: Less than 25% staining, Code 2: 25% - 50% staining, Code 3: 50% - 75% staining, Code 4: More than 75% staining and reported as proportional score and data were compared according to gender and lesion type using SPSS 22.0 Software and significance level of p Results: 60 blocks of 60 patients (30 males and 30 females) were included in the study. E-cadherin marker expression on IHC code I ( 0.05). Conclusion: The results of this study show that changes in cadherin expression in leukoplakia and lichen planus compared to squamous cell carcinoma can be considered as an important factor in the expression of dysplasia changes.},
 year = {2025}
}

Copy | Download

TY  - JOUR
T1  - Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma
AU  - Samira Mostafazadeh
AU  - Shahla Gharenaghadehi
AU  - Fariba Abdal
Y1  - 2025/12/09
PY  - 2025
N1  - https://doi.org/10.11648/j.ijcocr.20251004.14
DO  - 10.11648/j.ijcocr.20251004.14
T2  - International Journal of Clinical Oncology and Cancer Research
JF  - International Journal of Clinical Oncology and Cancer Research
JO  - International Journal of Clinical Oncology and Cancer Research
SP  - 151
EP  - 156
PB  - Science Publishing Group
SN  - 2578-9511
UR  - https://doi.org/10.11648/j.ijcocr.20251004.14
AB  - Objective: E-cadherin is a membranous glycoprotein that acts as an adhesive agent in intercellular communication, this marker level decreases in dysplastic condition, the aim of the present study is to evaluate the expression level of the mentioned marker on Oral Lichen Planus (OLP), Oral Leukoplakia (OL) and Oral Squamous Cell Carcinoma (OSCC) lesions. Methods: In this in-vitro study was conducted on 60 pararhyme blocks of patients with OL, OLP, and OSCC (n = 20) using Immunohistochemically (IHC) staining diagnosis were classified as follows: Code 0: Not painted Code 1: Less than 25% staining, Code 2: 25% - 50% staining, Code 3: 50% - 75% staining, Code 4: More than 75% staining and reported as proportional score and data were compared according to gender and lesion type using SPSS 22.0 Software and significance level of p Results: 60 blocks of 60 patients (30 males and 30 females) were included in the study. E-cadherin marker expression on IHC code I ( 0.05). Conclusion: The results of this study show that changes in cadherin expression in leukoplakia and lichen planus compared to squamous cell carcinoma can be considered as an important factor in the expression of dysplasia changes.
VL  - 10
IS  - 4
ER  -

Copy | Download

Author Information

Samira Mostafazadeh

Department of Oral and Maxillofacial Pathology, Urmia University of Medical Sciences, Urmia, Iran

Contact Email

http://orcid.org/0000-0002-8620-6127
Shahla Gharenaghadehi

Faculty of Dentistry, Urmia University of Medical Sciences, Urmia, Iran

Contact Email
Fariba Abdal

Department of Oral and Maxillofacial Pathology, Ilam University of Medical Sciences, Ilam, Iran

Contact Email

http://orcid.org/0000-0002-9391-6354

Download PDF

Submit an Article

Sections

Plain Text BibTeX RIS

APA Style

Mostafazadeh, S., Gharenaghadehi, S., Abdal, F. (2025). Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma. International Journal of Clinical Oncology and Cancer Research, 10(4), 151-156. https://doi.org/10.11648/j.ijcocr.20251004.14

Copy | Download

ACS Style

Mostafazadeh, S.; Gharenaghadehi, S.; Abdal, F. Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma. Int. J. Clin. Oncol. Cancer Res. 2025, 10(4), 151-156. doi: 10.11648/j.ijcocr.20251004.14

Copy | Download

AMA Style

Mostafazadeh S, Gharenaghadehi S, Abdal F. Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma. Int J Clin Oncol Cancer Res. 2025;10(4):151-156. doi: 10.11648/j.ijcocr.20251004.14

Copy | Download

@article{10.11648/j.ijcocr.20251004.14,
  author = {Samira Mostafazadeh and Shahla Gharenaghadehi and Fariba Abdal},
  title = {Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma},
  journal = {International Journal of Clinical Oncology and Cancer Research},
  volume = {10},
  number = {4},
  pages = {151-156},
  doi = {10.11648/j.ijcocr.20251004.14},
  url = {https://doi.org/10.11648/j.ijcocr.20251004.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20251004.14},
  abstract = {Objective: E-cadherin is a membranous glycoprotein that acts as an adhesive agent in intercellular communication, this marker level decreases in dysplastic condition, the aim of the present study is to evaluate the expression level of the mentioned marker on Oral Lichen Planus (OLP), Oral Leukoplakia (OL) and Oral Squamous Cell Carcinoma (OSCC) lesions. Methods: In this in-vitro study was conducted on 60 pararhyme blocks of patients with OL, OLP, and OSCC (n = 20) using Immunohistochemically (IHC) staining diagnosis were classified as follows: Code 0: Not painted Code 1: Less than 25% staining, Code 2: 25% - 50% staining, Code 3: 50% - 75% staining, Code 4: More than 75% staining and reported as proportional score and data were compared according to gender and lesion type using SPSS 22.0 Software and significance level of p Results: 60 blocks of 60 patients (30 males and 30 females) were included in the study. E-cadherin marker expression on IHC code I ( 0.05). Conclusion: The results of this study show that changes in cadherin expression in leukoplakia and lichen planus compared to squamous cell carcinoma can be considered as an important factor in the expression of dysplasia changes.},
 year = {2025}
}

Copy | Download

TY  - JOUR
T1  - Comparison of E-cadherin Marker Expression Between Lichen Planus, Leukoplakia and Oral Squamous Cell Carcinoma
AU  - Samira Mostafazadeh
AU  - Shahla Gharenaghadehi
AU  - Fariba Abdal
Y1  - 2025/12/09
PY  - 2025
N1  - https://doi.org/10.11648/j.ijcocr.20251004.14
DO  - 10.11648/j.ijcocr.20251004.14
T2  - International Journal of Clinical Oncology and Cancer Research
JF  - International Journal of Clinical Oncology and Cancer Research
JO  - International Journal of Clinical Oncology and Cancer Research
SP  - 151
EP  - 156
PB  - Science Publishing Group
SN  - 2578-9511
UR  - https://doi.org/10.11648/j.ijcocr.20251004.14
AB  - Objective: E-cadherin is a membranous glycoprotein that acts as an adhesive agent in intercellular communication, this marker level decreases in dysplastic condition, the aim of the present study is to evaluate the expression level of the mentioned marker on Oral Lichen Planus (OLP), Oral Leukoplakia (OL) and Oral Squamous Cell Carcinoma (OSCC) lesions. Methods: In this in-vitro study was conducted on 60 pararhyme blocks of patients with OL, OLP, and OSCC (n = 20) using Immunohistochemically (IHC) staining diagnosis were classified as follows: Code 0: Not painted Code 1: Less than 25% staining, Code 2: 25% - 50% staining, Code 3: 50% - 75% staining, Code 4: More than 75% staining and reported as proportional score and data were compared according to gender and lesion type using SPSS 22.0 Software and significance level of p Results: 60 blocks of 60 patients (30 males and 30 females) were included in the study. E-cadherin marker expression on IHC code I ( 0.05). Conclusion: The results of this study show that changes in cadherin expression in leukoplakia and lichen planus compared to squamous cell carcinoma can be considered as an important factor in the expression of dysplasia changes.
VL  - 10
IS  - 4
ER  -

Copy | Download